Circassia Pharmaceuticals's total assets for Q4 2024 were £68.40M, a decrease of -21.83% from the previous quarter. GB:NIOX total liabilities were £8.90M for the fiscal quarter, a 56.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.